Literature DB >> 10342666

Etiology of ovarian cancer: a proposed mechanism.

M Ghahremani1, A Foghi, J H Dorrington.   

Abstract

The majority of ovarian cancers are derived from ovarian surface epithelial cells that are sequestered in inclusion cysts within the ovarian stroma. We propose that the Fas/Fas ligand system is responsible for the normal elimination of these inclusion cysts through apoptosis, thereby removing potential sites of ovarian tumors. Furthermore, we hypothesize that the failure of the Fas/Fas ligand's apoptotic signaling mechanism leads to the persistence of these inclusion cysts in the stroma, and the onset of ovarian tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342666     DOI: 10.1054/mehy.1997.0620

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer.

Authors:  Jennifer L Dembinski; Shanna M Wilson; Erika L Spaeth; Matus Studeny; Claudia Zompetta; Ismael Samudio; Katherine Roby; Michael Andreeff; Frank C Marini
Journal:  Cytotherapy       Date:  2013-01       Impact factor: 5.414

Review 2.  Evaluating the progenitor cells of ovarian cancer: analysis of current animal models.

Authors:  Shelby M King; Joanna E Burdette
Journal:  BMB Rep       Date:  2011-07       Impact factor: 4.778

3.  The transcription factor GATA4 is required for follicular development and normal ovarian function.

Authors:  Evgeni Efimenko; Maria B Padua; Nikolay L Manuylov; Shawna C Fox; Deborah A Morse; Sergei G Tevosian
Journal:  Dev Biol       Date:  2013-06-14       Impact factor: 3.582

4.  Acellular fraction of ovarian cancer ascites induce apoptosis by activating JNK and inducing BRCA1, Fas and FasL expression in ovarian cancer cells.

Authors:  Marie Cohen; Sandra Pierredon; Christine Wuillemin; Florence Delie; Patrick Petignat
Journal:  Oncoscience       Date:  2014-04-30

5.  Circulating soluble Fas levels and risk of ovarian cancer.

Authors:  Arslan Akhmedkhanov; Eva Lundin; Seth Guller; Annekatrin Lukanova; Andrea Micheli; Yuehong Ma; Yelena Afanasyeva; Anne Zeleniuch-Jacquotte; Vittorio Krogh; Per Lenner; Paola Muti; Sabina Rinaldi; Rudolf Kaaks; Franco Berrino; Göran Hallmans; Paolo Toniolo
Journal:  BMC Cancer       Date:  2003-12-22       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.